JP2024057010A5 - - Google Patents

Download PDF

Info

Publication number
JP2024057010A5
JP2024057010A5 JP2024025657A JP2024025657A JP2024057010A5 JP 2024057010 A5 JP2024057010 A5 JP 2024057010A5 JP 2024025657 A JP2024025657 A JP 2024025657A JP 2024025657 A JP2024025657 A JP 2024025657A JP 2024057010 A5 JP2024057010 A5 JP 2024057010A5
Authority
JP
Japan
Prior art keywords
gel composition
cosmetic gel
permeation enhancer
composition
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024025657A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024057010A (ja
Filing date
Publication date
Priority claimed from PCT/US2017/015181 external-priority patent/WO2017132410A1/en
Application filed filed Critical
Publication of JP2024057010A publication Critical patent/JP2024057010A/ja
Publication of JP2024057010A5 publication Critical patent/JP2024057010A5/ja
Priority to JP2025162838A priority Critical patent/JP2026001122A/ja
Pending legal-status Critical Current

Links

JP2024025657A 2016-01-26 2024-02-22 アルファアドレナリン作動薬の組成物および使用 Pending JP2024057010A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025162838A JP2026001122A (ja) 2016-01-26 2025-09-30 アルファアドレナリン作動薬の組成物および使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662287391P 2016-01-26 2016-01-26
US62/287,391 2016-01-26
PCT/US2017/015181 WO2017132410A1 (en) 2016-01-26 2017-01-26 Compositions and uses of alpha-adrenergic agents
JP2018558113A JP2019509330A (ja) 2016-01-26 2017-01-26 アルファアドレナリン作動薬の組成物および使用
JP2022010224A JP2022058765A (ja) 2016-01-26 2022-01-26 アルファアドレナリン作動薬の組成物および使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022010224A Division JP2022058765A (ja) 2016-01-26 2022-01-26 アルファアドレナリン作動薬の組成物および使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025162838A Division JP2026001122A (ja) 2016-01-26 2025-09-30 アルファアドレナリン作動薬の組成物および使用

Publications (2)

Publication Number Publication Date
JP2024057010A JP2024057010A (ja) 2024-04-23
JP2024057010A5 true JP2024057010A5 (https=) 2024-11-07

Family

ID=59398678

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018558113A Withdrawn JP2019509330A (ja) 2016-01-26 2017-01-26 アルファアドレナリン作動薬の組成物および使用
JP2022010224A Pending JP2022058765A (ja) 2016-01-26 2022-01-26 アルファアドレナリン作動薬の組成物および使用
JP2024025657A Pending JP2024057010A (ja) 2016-01-26 2024-02-22 アルファアドレナリン作動薬の組成物および使用
JP2025162838A Pending JP2026001122A (ja) 2016-01-26 2025-09-30 アルファアドレナリン作動薬の組成物および使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2018558113A Withdrawn JP2019509330A (ja) 2016-01-26 2017-01-26 アルファアドレナリン作動薬の組成物および使用
JP2022010224A Pending JP2022058765A (ja) 2016-01-26 2022-01-26 アルファアドレナリン作動薬の組成物および使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025162838A Pending JP2026001122A (ja) 2016-01-26 2025-09-30 アルファアドレナリン作動薬の組成物および使用

Country Status (6)

Country Link
US (5) US10828252B2 (https=)
EP (1) EP3407976A4 (https=)
JP (4) JP2019509330A (https=)
CN (2) CN108883308A (https=)
AU (3) AU2017211793B2 (https=)
WO (1) WO2017132410A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120225918A1 (en) 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
CN108883308A (zh) 2016-01-26 2018-11-23 利维申制药有限公司 α-肾上腺素能药剂的组合物和用途
FI3541362T3 (fi) 2016-11-15 2026-02-05 Klaria Pharma Holding Ab Triptaania käsittävä alginaattikalvo
EP3595515A4 (en) 2017-03-14 2020-12-30 University of Connecticut BIODEGRADABLE PRESSURE SENSOR
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
EP3759213B1 (en) 2018-03-02 2026-04-29 Quantumcyte, Inc. Methods, compositions, and devices for isolation and expression analysis of regions of interest from a tissue
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
WO2020100142A1 (en) * 2018-11-15 2020-05-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Lactide containing polyester-polyethylene glycol triblock thermoresponsive copolymers
US11826495B2 (en) 2019-03-01 2023-11-28 University Of Connecticut Biodegradable piezoelectric ultrasonic transducer system
US10814001B1 (en) 2019-05-06 2020-10-27 Rvl Pharmaceuticals, Inc. Oxymetazoline compositions
US11745001B2 (en) 2020-03-10 2023-09-05 University Of Connecticut Therapeutic bandage
US12491290B2 (en) 2020-06-08 2025-12-09 University Of Connecticut Biodegradable piezoelectric composite materials
CN112791033A (zh) * 2020-12-30 2021-05-14 广东蕾琪化妆品有限公司 一种新型眼影及其制备方法
US20240225978A1 (en) * 2021-01-23 2024-07-11 Christine Lynn Bokman Methods and compositions for pharmacological treatment of blepharoptosis
CN113149022B (zh) * 2021-04-30 2022-07-22 南昌大学 一种二氧化硅@硅酸钙中空纳米球及其制备方法和应用
US11779553B1 (en) * 2022-11-28 2023-10-10 Atif B. D. Collins Methods and devices for treatment of eyelid ptosis

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2784127A (en) 1954-06-02 1957-03-05 Eastman Kodak Co Plasticized monomeric adhesive compositions and articles prepared therefrom
US3993073A (en) 1969-04-01 1976-11-23 Alza Corporation Novel drug delivery device
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4069307A (en) 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US3731683A (en) 1971-06-04 1973-05-08 Alza Corp Bandage for the controlled metering of topical drugs to the skin
US3742951A (en) 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) 1971-08-09 1976-12-14 Alza Corporation Medical bandage
BE795384A (fr) 1972-02-14 1973-08-13 Ici Ltd Pansements
US3921636A (en) 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US3993072A (en) 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US3972995A (en) 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4060084A (en) 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4201211A (en) 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
JPS5562012A (en) 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
US4230105A (en) 1978-11-13 1980-10-28 Merck & Co., Inc. Transdermal delivery of drugs
US4291015A (en) 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4444933A (en) 1982-12-02 1984-04-24 Borden, Inc. Adhesive cyanoacrylate compositions with reduced adhesion to skin
US4757128A (en) 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
US5462990A (en) 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US5633009A (en) 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
AU673160B2 (en) 1992-02-28 1996-10-31 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5665378A (en) 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US5654381A (en) 1995-06-16 1997-08-05 Massachusetts Institute Of Technology Functionalized polyester graft copolymers
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US5628863A (en) 1996-06-12 1997-05-13 Lee; Shu-Ken Pouch producing machine
US5869090A (en) 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6312612B1 (en) 1999-06-09 2001-11-06 The Procter & Gamble Company Apparatus and method for manufacturing an intracutaneous microneedle array
US6945952B2 (en) 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
US20090136598A1 (en) * 2006-04-26 2009-05-28 Aciex, Inc. Compositions for the Treatment and Prevention of Eyelid Swelling
CA2650592A1 (en) * 2006-04-26 2007-11-08 Aciex, Inc. Compositions for the treatment and prevention of eyelid swelling
JP2010535591A (ja) 2007-08-06 2010-11-25 トランスダーム， インコーポレイテッド ポリマー膜から形成される微小針アレイ
WO2009061431A2 (en) * 2007-11-08 2009-05-14 Aciex Therapeutics, Inc. Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor
WO2010118340A1 (en) * 2009-04-09 2010-10-14 University Of Medicine And Dentistry Of New Jersey Treatment of cutaneous hemangioma
US9034830B2 (en) * 2009-10-30 2015-05-19 Intratus, Inc. Methods and compositions for sustained delivery of drugs
US8883838B2 (en) 2010-12-03 2014-11-11 Allergan, Inc. Pharmaceutical cream compositions and methods of use
US20120225918A1 (en) * 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
RU2014104559A (ru) 2011-07-14 2015-08-20 Аллерган, Инк. Гелевые композиции оксиметазолина и способы их применения
US20130035338A1 (en) * 2011-08-05 2013-02-07 Gordon Tang Eyelid treatment
SG11201405643RA (en) 2012-03-16 2014-10-30 Univ Singapore A novel method to fabricate polymeric microneedles
EP2866607A4 (en) 2012-06-29 2016-07-13 Elc Man Llc SOLUBLE MICROARRAYS COMPRISING ONE OR MORE ENCAPSULATED COSMETIC INGREDIENTS
AU2015274532B2 (en) 2014-06-11 2020-06-11 Epi Health, Llc Stabilized oxymetazoline formulations and their uses
US20190000808A1 (en) 2015-07-13 2019-01-03 Allergan, Inc. Composition and methods for the treatment of blephopharoptosis
CN108883308A (zh) 2016-01-26 2018-11-23 利维申制药有限公司 α-肾上腺素能药剂的组合物和用途

Similar Documents

Publication Publication Date Title
JP2024057010A5 (https=)
JP2022058765A5 (https=)
JP4170751B2 (ja) 抗真菌マニキュア組成物
JP2021513520A5 (https=)
JP2010537988A5 (https=)
US20170112780A1 (en) Pharmaceutical composition for application to nail
JP6045663B2 (ja) 爪の成長速度を増大するためのキトサンの使用
JP2002512187A (ja) 爪真菌病の処置のための局所製剤
CN101641082A (zh) 用于向皮肤释放药物的形成表膜的液体制剂
WO2007094999A2 (en) Ungual antifungal compositions
EP2968197B1 (fr) Composition filmogène et son utilisation pour le traitement des affections cutanées
JP2004532268A (ja) 異常な角質性物質を除去するための製剤
KR20210065968A (ko) 심미적 피부 상태를 치료하기 위한 철 킬레이팅 화합물
US20050053564A1 (en) Use a plant extract to enhance hair growth and hair restoration for damaged hair
US11154542B2 (en) Nail lacquer composition containing ciclopirox
CN103732224B (zh) 用于眼睫毛生长的组合物
EP3378474B1 (en) Composition for the use in the treatment of plantar hyperhidrosis predisposing to cutaneous fungal infection of the foot
WO2022182900A9 (en) Skin serum
JP2024544404A5 (https=)
CN110302083A (zh) 一种化妆品用防腐剂及其制备方法和应用
HK1158541B (en) Use of chitosans to increase nail growth rate
HK1158541A (en) Use of chitosans to increase nail growth rate
HK1133189B (en) Use of chitosans to increase nail growth rate
HK1053067B (en) Antimycotic nail varnish composition